Medigen Vaccine Biologics Corporation Logo

Medigen Vaccine Biologics Corporation (6547)

TWSE

Currency in TWD
58.10
-0.70 (-1.19%)

Closed

Sep 14, 2026

Day's Range

56.50
59.30

52 wk Range

33.50
72.20

Overview - 6547 - Medigen Vaccine Biologics Corporation

Key Statistics

Valuation

Enterprise Value

20.10B

P/E (Trailing)

‪-71.39‬

P/E (Forward)

‪46.64‬

PEG Ratio

‪0.57‬

Price / Sales (TTM)

‪39.01‬

Price / Book

‪6.29‬

EV / EBITDA

‪-347.53‬

Profitability

Gross Margin

‪81.54%‬

Profit Margin

‪-29.06%‬

Operating Margin

‪18.58%‬

Return on Assets

‪-2.54%‬

Return on Equity

‪-4.61%‬

Ownership

Shares Outstanding

328.74M

Float

257.51M

Held by Insiders

‪23.80%‬

Held by Institutions

‪2.53%‬

Price stats

Beta

‪0.0040‬

50-Day Avg

‪51.61‬

200-Day Avg

‪45.21‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

1 analysts

News Teaser - 6547 - Medigen Vaccine Biologics Corporation

News & Analysis

View all news

Market Cap - 6547 - Medigen Vaccine Biologics Corporation

Peers - 6547 - Medigen Vaccine Biologics Corporation

Peer Comparison

Compared with companies in Biotechnology listed on TWSE.

Profile Summary - 6547 - Medigen Vaccine Biologics Corporation

About

Medigen Vaccine Biologics Corporation is a biotechnology company specializing in the research, development, and manufacturing of vaccines and biopharmaceuticals. Founded in 2012 and headquartered in Zhubei City, Taiwan, the company is dedicated to addressing global and regional infectious diseases, operating with…

SectorHealthcare
IndustryBiotechnology
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.